Literature DB >> 30994073

BRCA1/2 Variant Data-Sharing Practices.

Juli M Bollinger1, Abhi Sanka1, Lena Dolman1, Rachel G Liao1, Robert Cook-Deegan1.   

Abstract

Accessing BRCA1/2 data facilitates the detection of disease-associated variants, which is critical to informing clinical management of risks. BRCA1/2 data sharing is complex and many practices exist. We describe current BRCA1/2 data-sharing practices, in the United States and globally, and discuss obstacles and incentives to sharing, based on 28 interviews with personnel at U.S. and non-U.S. clinical laboratories and databases. Our examination of the BRCA1/2 data-sharing landscape demonstrates strong support for and robust sharing of BRCA1/2 data around the world, increasing global accesses to diverse data sets.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30994073      PMCID: PMC6748872          DOI: 10.1177/1073110519840487

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


  17 in total

Review 1.  Clinical management of BRCA1 and BRCA2 mutation carriers.

Authors:  S M Domchek; B L Weber
Journal:  Oncogene       Date:  2006-09-25       Impact factor: 9.867

2.  MYRIAD AFTER MYRIAD: THE PROPRIETARY DATA DILEMMA.

Authors:  John M Conley; Robert Cook-Deegan; Gabriel Lázaro-Muñoz
Journal:  N C J Law Technol       Date:  2014-06

3.  GENOMICS. A federated ecosystem for sharing genomic, clinical data.

Authors: 
Journal:  Science       Date:  2016-06-10       Impact factor: 47.728

4.  BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.

Authors:  Michael J Hall; Julia E Reid; Lynn A Burbidge; Dmitry Pruss; Amie M Deffenbaugh; Cynthia Frye; Richard J Wenstrup; Brian E Ward; Thomas A Scholl; Walter W Noll
Journal:  Cancer       Date:  2009-05-15       Impact factor: 6.860

5.  The impact of human gene patents on genetic testing in the United Kingdom.

Authors:  Naomi Hawkins
Journal:  Genet Med       Date:  2011-04       Impact factor: 8.822

6.  Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk.

Authors:  Jennifer L Caswell-Jin; Tanya Gupta; Evan Hall; Iva M Petrovchich; Meredith A Mills; Kerry E Kingham; Rachel Koff; Nicolette M Chun; Peter Levonian; Alexandra P Lebensohn; James M Ford; Allison W Kurian
Journal:  Genet Med       Date:  2017-07-27       Impact factor: 8.822

7.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

8.  Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come?

Authors:  Jae Yeon Cheon; Jessica Mozersky; Robert Cook-Deegan
Journal:  Genome Med       Date:  2014-12-19       Impact factor: 11.117

9.  Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.

Authors:  Gabriela C Fernandes; Rodrigo A D Michelli; Henrique C R Galvão; André E Paula; Rui Pereira; Carlos E Andrade; Paula S Felicio; Cristiano P Souza; Deise R P Mendes; Sahlua Volc; Gustavo N Berardinelli; Rebeca S Grasel; Cristina S Sabato; Danilo V Viana; Edmundo C Mauad; Cristovam Scapulatempo-Neto; Banu Arun; Rui M Reis; Edenir I Palmero
Journal:  Oncotarget       Date:  2016-12-06

10.  Guidelines for diagnostic next-generation sequencing.

Authors:  Gert Matthijs; Erika Souche; Mariëlle Alders; Anniek Corveleyn; Sebastian Eck; Ilse Feenstra; Valérie Race; Erik Sistermans; Marc Sturm; Marjan Weiss; Helger Yntema; Egbert Bakker; Hans Scheffer; Peter Bauer
Journal:  Eur J Hum Genet       Date:  2015-10-28       Impact factor: 4.246

View more
  1 in total

1.  A proposed framework for patient engagement throughout the broader research enterprise.

Authors:  Camila L Strassle; Steven D Pearson
Journal:  J Comp Eff Res       Date:  2020-04-07       Impact factor: 1.744

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.